STSS - Sharps Technology Inc


1.88
0.050   2.660%

Share volume: 324,230
Last Updated: 04-24-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%

$1.83
0.05
0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
33%
Profitability 35%
Dept financing 36%
Liquidity 31%
Performance 30%
Company vs Stock growth
vs
Performance
5 Days
-3.59%
1 Month
18.99%
3 Months
-18.26%
6 Months
-65.25%
1 Year
-66.90%
2 Year
630.66%
Key data
Stock price
$1.88
P/E Ratio 
0.00
DAY RANGE
$1.82 - $1.92
EPS 
$30.59
52 WEEK RANGE
$1.42 - $18.23
52 WEEK CHANGE
-$66.90
MARKET CAP 
6.671 M
YIELD 
N/A
SHARES OUTSTANDING 
28.226 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-13-2025
BETA 
1.08
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$345,296
AVERAGE 30 VOLUME 
$405,135
Company detail
CEO: Robert M. Hayes
Region: US
Website: sharpstechnology.com
Employees: 3
IPO year: 2022
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Sharps Technology Inc. researches, designs, develops, manufactures, distributes, and sells safety syringe products. Sharps Provensa is an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.

Recent news